The global pharmaceutical industry is witnessing an unprecedented surge in demand for reliable packaging materials. Polyvinyl Chloride (PVC) film remains the cornerstone of pharmaceutical blister packaging due to its exceptional clarity, thermoforming properties, and cost-effectiveness. As of 2024, the global market for pharmaceutical grade PVC film is expanding rapidly, driven by the growth of the generic drug market and the increasing healthcare infrastructure in emerging economies across Southeast Asia, Latin America, and Africa.
Industrial giants in Europe and North America are increasingly looking toward China for high-volume supply chain partnerships. The shift is not merely due to cost but also because Chinese manufacturers like Jiangsu Dahai Plastics have invested heavily in Clean Room environments (Class 100,000) and advanced calendering technology that meets strict international pharmacopoeia standards (USP, EP, and ChP).
The industry is moving toward "Ultra-High Barrier" PVC films. By utilizing multi-layer co-extrusion, we can now provide films that match the shelf-life stability of cold-form aluminum while maintaining the visibility of traditional blisters.
Eco-friendly initiatives are pushing factories to develop recyclable PVC composites or thinner films that reduce plastic waste without compromising the integrity of medical products.
The integration of RFID tags and QR codes directly onto the PVC surface during the printing phase is rising, allowing for better anti-counterfeiting and patient adherence tracking.
Procurement managers from pharmaceutical companies worldwide—from large-scale multinational corporations (MNCs) to regional contract manufacturing organizations (CMOs)—require more than just a product; they require a "validated" supply source. Global procurement needs center around three pillars: Consistency, Compliance, and Continuity.
In local markets, such as in India or Brazil, the demand for "Tropical Blisters" (PVC/PVDC/Alu) is high due to extreme humidity, whereas in cooler climates, standard rigid PVC film suffices for most OTC medications.
Jiangsu Dahai Plastics Co., Ltd. was founded in 1996, is a professional production of various types of PVC film and printing PVC film technology of private enterprises. We mainly produce super transparent film, ordinary transparent film, toy film, bath film, raincoat film, electrical tape film, cold film, non-stick film, decorative film, PEVA film, particles, tablecloth, shower curtain, urine bag.
The company has more than 20 production lines, more than 450 employees, of which 30% are technical management personnel, and has a sound management system. Covers an area of more than 120,000 square meters, annual output of more than 100,000 tons, annual sales of more than 1 billion. The company continues to introduce advanced production equipment and technology.
120,000+
Cover area (sqm)
20+
Production Lines
450+
Expert Staff
100,000+
Annual Output (Tons)
We possess laboratories accredited by China National Commission for Conformity Assessment (CNAS), which are equipped with many kinds of world advanced experimental equipment and physical and chemical testing-analysis instruments. In every experiment, in every test, even the slightest difference can be detected by our machines, which greatly guarantees the quality of our products.
DAHAI continues to invest resources, and we will work with university teams to develop products. Our technical department is constantly learning new technologies and combining them with our own situation, through which our ability to innovate is keeping improving.
Make green materials, create a good and healthy life!
To become the domestic polymer material application industry leader, to build a world-class brand!
Independent innovation intelligent future! Team style: people-oriented safety first!
Beyond Pharmaceutical Packaging, We serve Global Industrial sectors.
Daily Necessities
Industrial Purpose
Toy Manufacturing
Medical Field
Equipped with Agilent GC analyzers, gloss meters, and universal testing machines.
Dahai Plastic
